Article Text

PDF

Chemoprophylaxis of respiratory infections
  1. John Batten

    Abstract

    Chemoprophylaxis of certain respiratory infections has been described. The benefit and cost of chemoprophylaxis of tuberculosis have been compared and indications outlined. While some protection against influenzal infection by drugs of the adamantane group has been demonstrated, chemoprophylaxis against respiratory virus infections is as yet unavailable or impractical. In diseases associated with impaired bronchial clearance the influence of long term chemoprophylaxis on the natural history of the disorders becomes less certain. Morbidity in chronic bronchitis and bronchiectasis may be reduced. In cystic fibrosis, however, although the prognosis has been undoubtedly improved by chemoprophylaxis, the effects of long term treatment of infection in the later stages are uncertain.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.